Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Bayesian Capital Management LP

Bayesian Capital Management LP lessened its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 82.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,600 shares of the real estate investment trust's stock after selling 94,500 shares during the period. Bayesian Capital Management LP's holdings in Healthpeak Properties were worth $418,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of DOC. Barclays PLC acquired a new stake in Healthpeak Properties during the third quarter worth approximately $35,078,000. World Investment Advisors LLC purchased a new stake in Healthpeak Properties during the 3rd quarter valued at approximately $291,000. Wilmington Savings Fund Society FSB acquired a new stake in Healthpeak Properties during the 3rd quarter worth approximately $125,000. Tidal Investments LLC acquired a new stake in shares of Healthpeak Properties during the third quarter worth $1,586,000. Finally, Franklin Resources Inc. acquired a new position in Healthpeak Properties in the 3rd quarter valued at $3,224,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Price Performance

DOC stock traded up $0.11 during trading on Friday, hitting $17.50. The stock had a trading volume of 4,245,778 shares, compared to its average volume of 4,950,215. The stock has a market cap of $12.16 billion, a price-to-earnings ratio of 50.00, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The company's 50 day moving average price is $19.14 and its two-hundred day moving average price is $20.29. Healthpeak Properties, Inc. has a 1-year low of $17.21 and a 1-year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. During the same quarter in the previous year, the business posted $0.45 earnings per share. The company's revenue was up 15.9% on a year-over-year basis. On average, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Wednesday, April 30th. Stockholders of record on Friday, April 18th were given a $0.1017 dividend. This represents a dividend yield of 6.5%. The ex-dividend date of this dividend was Thursday, April 17th. Healthpeak Properties's dividend payout ratio is currently 305.00%.

Insider Activity at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 11,337 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the transaction, the chief executive officer now owns 201,863 shares of the company's stock, valued at $3,568,937.84. This represents a 5.95 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director John T. Thomas purchased 4,200 shares of the stock in a transaction on Monday, April 28th. The shares were purchased at an average cost of $17.84 per share, with a total value of $74,928.00. Following the transaction, the director now owns 813,566 shares of the company's stock, valued at $14,514,017.44. This trade represents a 0.52 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.23% of the company's stock.

Wall Street Analyst Weigh In

DOC has been the topic of several analyst reports. Morgan Stanley raised shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Thursday, May 1st. Scotiabank reduced their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research note on Friday, February 28th. Argus restated a "buy" rating and set a $25.00 target price on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Finally, Evercore ISI reduced their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and an average price target of $23.42.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.